Skip to main content

miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis.

Publication ,  Journal Article
Pan, D; Du, Y; Li, R; Shen, A; Liu, X; Li, C; Hu, B
Published in: Front Cell Dev Biol
2021

Radioresistance conferred by cancer stem cells (CSCs) is the principal cause of the failure of cancer radiotherapy. Eradication of CSCs is a prime therapeutic target and a requirement for effective radiotherapy. Three dimensional (3D) cell-cultured model could mimic the morphology of cells in vivo and induce CSC properties. Emerging evidence suggests that microRNAs (miRNAs) play crucial roles in the regulation of radiosensitivity in cancers. In this study, we aim to investigate the effects of miRNAs on the radiosensitivity of 3D cultured stem-like cells. Using miRNA microarray analysis in 2D and 3D cell culture models, we found that the expression of miR-29b-3p was downregulated in 3D cultured A549 and MCF7 cells compared with monolayer (2D) cells. Clinic data analysis from The Cancer Genome Atlas database exhibited that miR-29b-3p high expression showed significant advantages in lung adenocarcinoma and breast invasive carcinoma patients' prognosis. The subsequent experiments proved that miR-29b-3p overexpression decreased the radioresistance of cells in 3D culture and tumors in vivo through interfering kinetics process of DNA damage repair and inhibiting oncogenes RBL1, PIK3R1, AKT2, and Bcl-2. In addition, miR-29b-3p knockdown enhanced cancer cells invasion and migration capability. MiR-29b-3p overexpression decreased the stemness of 3D cultured cells. In conclusion, our results demonstrate that miR-29b-3p could be a sensitizer of radiation killing in CSC-like cells via inhibiting oncogenes expression. MiR-29b-3p could be a novel therapeutic candidate target for radiotherapy.

Duke Scholars

Published In

Front Cell Dev Biol

DOI

ISSN

2296-634X

Publication Date

2021

Volume

9

Start / End Page

741074

Location

Switzerland

Related Subject Headings

  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pan, D., Du, Y., Li, R., Shen, A., Liu, X., Li, C., & Hu, B. (2021). miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis. Front Cell Dev Biol, 9, 741074. https://doi.org/10.3389/fcell.2021.741074
Pan, Dong, Yarong Du, Rong Li, Aihua Shen, Xiaodong Liu, Chuanyuan Li, and Burong Hu. “miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis.Front Cell Dev Biol 9 (2021): 741074. https://doi.org/10.3389/fcell.2021.741074.
Pan D, Du Y, Li R, Shen A, Liu X, Li C, et al. miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis. Front Cell Dev Biol. 2021;9:741074.
Pan, Dong, et al. “miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis.Front Cell Dev Biol, vol. 9, 2021, p. 741074. Pubmed, doi:10.3389/fcell.2021.741074.
Pan D, Du Y, Li R, Shen A, Liu X, Li C, Hu B. miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis. Front Cell Dev Biol. 2021;9:741074.

Published In

Front Cell Dev Biol

DOI

ISSN

2296-634X

Publication Date

2021

Volume

9

Start / End Page

741074

Location

Switzerland

Related Subject Headings

  • 32 Biomedical and clinical sciences
  • 31 Biological sciences